文献速递青光眼

医疗补助计划参保者与商业医疗保险参保者在接受青光眼诊疗方面的巨大差异

Large Disparities in Receipt of Glaucoma Care between Enrollees in Medicaid and Those with Commercial Health Insurance.
PubMed 文献 · Ophthalmology · 2017-06-02

这项回顾性纵向队列研究纳入21766例2007至2011年间新诊断开角型青光眼(OAG)的40岁及以上患者,比较医疗补助计划(Medicaid)与商业医疗保险参保者在诊断后15个月内接受视野检查、眼底照相或其他眼部影像检查的比例。结果显示Medicaid参保者接受各项检查的比例均更低,未接受任何青光眼检查的比值比(OR)为3.34(95%CI 3.07-3.63),且黑种人差异最为显著。

要点

  • 商业保险组接受视野检查、眼底照相和其他眼部影像的比例分别为63%、22%和54%,Medicaid组分别为35%、19%和30%。
  • 与商业保险参保者相比,Medicaid参保者未接受任何青光眼检查的OR为3.34(95%CI 3.07-3.63)。
  • 白种人Medicaid参保者未接受检查的OR为2.98(95%CI 2.66-3.33),黑种人Medicaid参保者为3.91(95%CI 3.40-4.49)。

核心结论

  • 不论种族/族裔,Medicaid参保的OAG患者接受的青光眼检查显著少于商业医疗保险参保者。
  • 所有种族/族裔均存在检查差异,其中黑种人最为显著。
  • 作者认为这些发现令人不安,因为黑种人比白种人更可能因OAG失明,且Medicaid中黑种人比例过高;需要努力改善Medicaid参保者尤其是少数族裔的青光眼诊疗质量。

研究设计与样本

  • 回顾性纵向队列研究,纳入2007至2011年间新诊断OAG的40岁及以上患者21766例,其中商业医疗保险18372例,Medicaid 3394例。
  • 评估初始OAG诊断后15个月内接受视野检查、眼底照相、其他眼部影像或未接受任何上述检查的比例。
  • 采用多变量逻辑回归评估保险类型和种族/族裔对接受青光眼检查 odds 的影响。

主要发现

  • 商业保险组接受视野检查、眼底照相和其他眼部影像的比例分别为63%、22%和54%;Medicaid组分别为35%、19%和30%。
  • 与商业保险参保者相比,Medicaid参保者未接受任何青光眼检查的OR为3.34(95%CI 3.07-3.63)。
  • 调整混杂因素后,白种人Medicaid参保者未接受任何青光眼检查的OR为2.98(95%CI 2.66-3.33),黑种人Medicaid参保者为3.91(95%CI 3.40-4.49)。

临床怎么用

  • 作者认为需要努力改善Medicaid参保者尤其是少数族裔的青光眼诊疗质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine whether the type of health insurance a patient possesses and a patient's race/ethnicity affect receipt of common tests to monitor open-angle glaucoma (OAG). DESIGN: Retrospective longitudinal cohort study. PARTICIPANTS: A total of 21 766 persons aged ≥40 years with newly diagnosed OAG between 2007 and 2011 enrolled in Medicaid or a large United States managed care network. METHODS: We determined the proportion of patients with newly diagnosed OAG who underwent visual field (VF) testing, fundus photography (FP), other ocular imaging (OOI), or none of these tests within the first 15 months after initial OAG diagnosis. Multivariable logistic regression was used to assess the extent by which health insurance type and race/ethnicity affected the odds of undergoing glaucoma testing. MAIN OUTCOME MEASURES: Odds ratios (OR) of undergoing VF testing, FP, OOI, or none of these tests in the 15 months after initial OAG diagnosis with 95% confidence intervals (CI). RESULTS: A total of 18 372 persons with commercial health insurance and 3394 Medicaid recipients met the study inclusion criteria. The proportions of persons with commercial health insurance with newly diagnosed OAG who underwent VF, FP, and OOI were 63%, 22%, and 54%, respectively, whereas the proportions were 35%, 19%, and 30%, respectively, for Medicaid recipients. Compared with those with commercial health insurance, Medicaid recipients were 234% more likely to not receive any glaucoma testing in the 15 months after initial diagnosis (OR = 3.34; 95% CI, 3.07-3.63). After adjustment for confounders, whites with OAG enrolled in Medicaid had 198% higher odds of receiving no glaucoma testing compared with whites possessing commercial health insurance (OR = 2.98; 95% CI, 2.66-3.33). Blacks with Medicaid insurance demonstrated 291% higher odds (OR = 3.91; 95% CI, 3.40-4.49) of not receiving any glaucoma testing compared with blacks with commercial health insurance. CONCLUSIONS: Irrespective of race/ethnicity, Medicaid recipients with OAG are receiving substantially less glaucoma testing compared with persons with commercial health insurance. Disparities in testing are observed across all races/ethnicities but were most notable for blacks. These findings are particularly disconcerting because blacks are more likely than whites to go blind from OAG and there are disproportionately more blacks in Medicaid. Efforts are needed to improve the quality of glaucoma care for Medicaid recipients, especially racial minorities.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Elam AR, Andrews C, Musch DC, et al. Large Disparities in Receipt of Glaucoma Care between Enrollees in Medicaid and Those with Commercial Health Insurance. Ophthalmology. 2017. PMID: 28583710. doi:10.1016/j.ophtha.2017.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。